Your trusted destination for CME, CPD & Medical Education across the Middle East.
Sidra Medicine
Dr. Chiara Cugno is an internationally distinguished physician-scientist, pediatric hematologist-oncologist, and cellular therapy expert operating within Qatar’s academic health system. She earned her Doctor of Medicine (MD) degree in Italy,followed by post-graduate clinical residency training in pediatrics and subspecialty fellowship training in pediatric hematology, oncology, and stem cell transplantation. She further specialized in advanced cell therapies, bone marrow processing, and regenerative medicine techniques through elite European and international clinical centers.
Currently serving as the Director of the Advanced Cell Therapy Core and Senior Attending Physician at Sidra Medicine in Doha, Qatar, Dr. Cugno occupies a vital intersection between laboratory scientific innovation and high-acuity clinical care. She also holds an academic appointment at Weill Cornell Medicine–Qatar (WCM-Q). Under her leadership, the Advanced Cell Therapy Core facility develops, processes, and validates cellular products—including cord blood derivatives, stem cell transplants, and novel immunotherapies—to treat complex pediatric, neonatal, and hematological conditions.
Her research portfolio encompasses translational stem cell biology, bone marrow failure syndromes, umbilical cord blood processing, and cellular therapies for tissue repair in neonates. Recognizing the unique physiological vulnerabilities of neonates in the Neonatal Intensive Care Unit (NICU), Dr. Cugno has been a pioneer in integrating clinical audit methodologies into routine transfusion practices, stem cell banking standards, and neonatal blood-product management.Her work in clinical governance and quality audit focuses on minimizing donor exposure, standardizing blood component administration in extreme pre-term infants, and tracking long-term developmental outcomes.
As an active contributor to international research networks, Dr. Cugno has published extensively in high-impact peer-reviewed medical journals on pediatric cell therapy, stem cell transplantation outcomes, and quality metrics in biobanking.She frequently serves on international advisory boards, scientific review panels, and hospital-wide quality assurance committees.
At the NICU Research & Clinical Audit Day, Dr. Cugno brings her multi-faceted expertise as a clinician, cell therapy director, and audit lead to the forefront. Keynoting sessions and moderating clinical research tracks, she emphasizes the indispensable role of rigorous clinical audits in closing the gap between innovative laboratory research and bedside neonatal care, fostering continuous quality improvement across tertiary NICU settings in the region.

Sidra Medicine
Sidra Medicine